Summary
The clinical, neuropathological and experimental evidence for implicating iron in the genesis of certain degenerative diseases of the central nervous system is briefly considered. Even if focal accumulation by decompartmentalisation of iron is a significant event — primarily or secondarily — and an effective selective chelating agent was available, demonstration of efficacy might prove difficult.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ben-Shachar D, Eshel G, Finberg APM, Youdim MBH (1991) The iron chelator desferrioxamine (Desferal) retards 6-hydroxy-dopamine-induced degeneration of nigrostriatal dopamine neurons. J Neurochem 56: 1441–1444
Berlin I (1953) The Hedgehog and the Fox. Weidenfeld & Nicolson
Braughler JM, Pregenzer JF Chase RL, Ducan LA, Jacobson EJ, McCall JM (1987) Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation. J Biol Chem 262: 10438–10440
Cohen RE (1992) Origin of ferro-electricity in perovskite oxides. Nature 358: 136
Cordy DR (1954) Nigro-pallidal encephelomalacia in horses associated with ingestion of Yellow Star thistle. J Neuropathol Exp Neurol 13: 330–342
Drayer BP, Olanow CW, Burger F (1986) High field strength resonance imaging in patients with Parkinson’s disease. Neurology 36: 1: 309–311
Hallervorden J, Spatz H (1922) Eigenartige Erkrankung im extrapyramidalen System mit besonderer Beteiligung des Globus pallidus and der Substantia nigra. Z Ges Neurol Psychiat 79: 254–302
Hofvander NY (1968) Haematological investigations in Ethiopia with special reference to a high iron intake. Acta Med Scand [Suppl] 494: 1965–1967; Neurology 36 (1): 310
Mettler FA, Stern GM (1962) Observations on the toxic effect of Yellow Star thistle. J Neuropathol Exp Neurol 22: 164–169
Pick A (1903) Weiterer Beitrag zur Pathologie der Tetanie nebst einer Bemerkung zur Chemie verkalkter Hirngefäße. Neurol 262: 22: 754–756
Pattie TS. The Manuscript Collection. The British Library (personal communication)
Pick A (1903) Weiterer Beitrag zur Pathologie der Tetanie nebst einer Bemerkung zur Chemie verkalkter Hirngefäße. Neurol 262: 22: 754–756
Roy DN, Craig AM, Blythe LL, Kayton RE, Spencer PS (1993) Partial isolation of excitotoxic agents from Yellow Star thistle (Centauria solstialis). A cause of equine nigro-striatal degeneration. Neurodegeneration (in press)
Rybicki BA Johnson CJ, Yuman J, Gorell AM (1993) Parkinson’s disease mortality and the industrial use of heavy metals in Michigan. Mov Disord 8: 1: 87–92
Sofic E, Paulus W, Jellinger K, Riederer P, Youdim MBH (1991) Selective increase of iron in substantia nigra and zona compacta in parkinsonian brain. J Neurochem 56: 978–982
Stern GM (1987) Vitamin E and Parkinson’s disease. Lancet i: 508
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag/Wien
About this paper
Cite this paper
Stern, G. (1993). Iron therapy: Pros and Cons. In: Riederer, P., Youdim, M.B.H. (eds) Iron in Central Nervous System Disorders. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9322-8_15
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9322-8_15
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82520-4
Online ISBN: 978-3-7091-9322-8
eBook Packages: Springer Book Archive